GE Healthcare has recently announced that it has received FDA 510(k) clearance for its latest addition to the image-guided system (IGS) lineup, the Allia IGS Pulse. This advanced system is designed to offer superior imaging capabilities while ensuring the right dose for complex cardiology interventions, without being impacted by the patient's size. Allia IGS Pulse is crafted to provide a customizable workspace that meets the specific preferences and requirements of the operator.
Notably, the Allia IGS Pulse features a groundbreaking monopolar x-ray tube within its imaging chain, which not only boasts powerful performance but also operates quietly, creating an ideal environment during medical procedures. The compact design of this tube enables clinicians to reach steep angulations, enhancing their ability to understand the intricate details of coronary artery anatomy, even with 30cm detector configurations.
What sets this system apart is the incorporation of the latest MyIQ technology, which allows clinicians to select their preferred image style with a simple click, providing a tailored experience without the need for additional radiation exposure.
In the realm of treating complex cardiovascular conditions, the quality of images and optimized dose management remains crucial for healthcare professionals. Allia IGS Pulse ensures exceptional image quality for large and bariatric patients with a BMI exceeding 30. The system's reduced pulse width and high X-ray peak power work to reduce motion blur, leading to better visualization of moving elements like vessels and medical devices.
To simplify the complex task of optimizing image quality and dose during procedures, Allia IGS Pulse employs AutoRight PLUS, the next generation of its automation platform, which leverages AI. With AutoRight PLUS, the system dynamically optimizes seven parameters in real time, including Focal Spot Shape, reducing the need for manual adjustments and allowing clinicians to stay focused on patient care during procedures.
Furthermore, a comprehensive suite of tools is available to support dose efficiency, reduction, and dose awareness throughout the image chain, ensuring that patient safety and image quality remain top priorities during medical interventions.
Source: https://www.businesswire.com/news/home/20231016347394/en/GE-HealthCare-Receives-FDA-Clearance-of-Allia-IGS-Pulse---the-Next-Generation-of-Image-Guided-Systems-Designed-for-Cardiac-Imaging-Excellence
